Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks Dec 25 22:00

3 Reasons Growth Investors Will Love Halozyme Therapeutics (HALO)

Zacks Dec 24 00:55

Express News | Halozyme Therapeutics Inc : JP Morgan Raises Target Price to $55 From $54

BreakingsDec 23 12:35

Those Who Invested in Halozyme Therapeutics (NASDAQ:HALO) Five Years Ago Are up 159%

Simply Wall StDec 20 18:57

HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $68 Price Target

BenzingaDec 18 19:16 · Ratings

Johnson & Johnson Says Injectable Rybrevant Rejected by FDA

Seeking AlphaDec 17 19:48